{
    "2021-04-06": [
        [
            {
                "time": "2021-04-06",
                "original_text": "挤进医保后的高值抗癌药：患者开不到，入院落地难，如何破局？",
                "features": {
                    "keywords": [
                        "医保",
                        "抗癌药",
                        "患者",
                        "入院",
                        "破局"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "公告精选丨“公募一哥”30亿狂买这只股！两市首份一季报出炉",
                "features": {
                    "keywords": [
                        "公募一哥",
                        "30亿",
                        "一季报"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "医药生物行业周报：持续把握财报季医药行情 长处方新政利好药店",
                "features": {
                    "keywords": [
                        "医药生物",
                        "财报季",
                        "长处方",
                        "新政",
                        "药店"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "中纪委严查医药腐败，有药企还在冒险",
                "features": {
                    "keywords": [
                        "中纪委",
                        "医药腐败",
                        "药企",
                        "冒险"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "A股共发生61宗大宗交易成交17.76亿元（4月6日）",
                "features": {
                    "keywords": [
                        "A股",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "恒瑞医药今日大宗交易成交110万股，成交价90.9元溢价0.0%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "医药行业2021年4月投资月报：把握一季报最佳反弹窗口期 加配低估值且高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}